Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Massari F, Mollica V, Kopp RM, Grande E, Fiala O, Kanesvaran R, Li H, Schieber TJ, Juan Fita MJ, Poprach A, Lolli C, Bourlon MT, de Liaño AG, Grillone F, Sunela K, Rizzo A, Ghosn M, Cerbone L, Taha T, Ürün Y, Molina-Cerrillo J, Alonso-Gordoa T, Lenci E, Martin IO, Abu-Sini H, Rescigno P, Bhuva D, Fay AP, Conteduca V, Yildirim A, Rosellini M, Akova U, Tassinari E, Bölek H, Soares A, Marques Monteiro FS, Buti S, Bilen MA, Santoni M.

    Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study.

    European Urology Focus . : .

    [doi:10.1016/j.euf.2025.05.020]

  • Fernandes C, Viegas V, Artiles Medina A, Martins Silva C, San José L, López-Fando Lavalle L.

    Male pudendal nerve release assisted by laparoscopy and intraoperative neurophysiologic monitoring.

    Neurocirugia (english Edition) . : 500714-500714.

    [doi:10.1016/j.neucie.2025.500714]

  • Fernández O, Molina A, Anido-Herranz U, Alvarez C, Gironés R, Gajate P, Domínguez RG, Ros S, Puente J, Blasco S, Oré-Arce M, Martinez EN, Fernández-Freire A, Del Pozo N, Cassinello J, Lázaro-Quintela M, Arranz F, Crespo G, Abad MT, Llorente M, Sánchez-Hernández A, Juan MJ.

    Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-025-03978-y]

  • Capdevila J, Hernando J, Molina-Cerrillo J, Benavent Viñuales M, Garcia-Carbonero R, Teulé A, Custodio A, Jimenez-Fonseca P, Lopez C, Hierro C, Carmona-Bayonas A, Alonso V, Llanos M, Sevilla I, Garcia-Alvarez A, Alonso-Gordoa T, Gallego Jiménez I, Antón-Pascual B, Modrego Sánchez A, Grande E.

    Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A multi-cohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).

    CLINICAL CANCER RESEARCH . : .

    [doi:10.1158/1078-0432.CCR-25-2143]

  • Molina-Cerrillo J, Catto J, Kamat AM, Necchi A, Roupre T M, Grande E.

    Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder Cancer.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2025.09.006]

  • Ocanto A, Ciérvide R, Hevia-Palacios V, García R, Gómez V, Cruz P, Olavarría A, Couñago F, López-Campos F.

    Ablative techniques in renal tumours for inoperable patients: Step forward in SBRT.

    Actas Urologicas Espanolas . : 501857-501857.

    [doi:10.1016/j.acuroe.2025.501857]

  • Powles T, Hussain SA, Climent MA, Carbonero IG, Molina-Cerrillo J, Puente J, Borrega P, Malik J, Dourthe LM, Jones R, Castellano D, Durán I, Loriot Y, Priyadarshini G, Szabados B, Jamal F, Wang YQ, Kotriwala N, Jackson-Spence F, Ackerman C, Grande E.

    Three versus six cycles of platinum-based chemotherapy followed by avelumab maintenance as first-line treatment for advanced urothelial cancer: the phase II DISCUS trial.

    Annals of oncology : official journal of the European Society for Medical Oncology . : .

    [doi:10.1016/j.annonc.2025.10.011]

  • Artiles Medina A, Mínguez Ojeda C, Subiela JD, López Curtis D, Domínguez Gutiérrez A, Chamorro Tojeiro S, de la Parra Sánchez I, Jiménez Cidre MÁ, Gómez Dos Santos V, Burgos Revilla FJ.

    A systematic review and meta-analysis evaluating the incidence, microbiological profile and risk factors associated with urinary tract infection after radical cystectomy.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . : .

    [doi:10.1016/j.urolonc.2025.09.027]

  • Vivas D, Ferrandis R, Anguita-Sánchez M, Anguita-Gámez M, Arcelus JI, Echeverri M, Egocheaga I, Esteve-Pastor MA, Ferreiro JL, Llau JV, Roldán V, Ruiz-Nodar JM, González-Casal D, Torres-Fonseca M, López-Menéndez J, Ciria M, Leyva F, Rodríguez de Santiago E, Vidán MT, Pamplona L, Mingot-Castellano ME, Mateo-Arranz J, Polo J, Castellanos Á, Llanos C, Madridano O, Jiménez S, Freijo MDM, Puchades MJ, Lafuente J, Jiménez D, Santos-Bueso E, Ferrandis E, Figuero E, González-Nieto CJ, Castel A, Hermida JF, Marín F, Rodríguez-Padial L, Fernández-Lozano I, Hidalgo F, Cassinello C, Muñoz E, Palomo-López N.

    Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU.

    Revista espanola de cardiologia (English ed.) . : .

    [doi:10.1016/j.rec.2025.09.003]

  • Del Giudice F, Santarelli V, Laszkiewicz J, Li S, Krajewski W, Nowak L, Szydelko T, Ferro M, Rocco B, Crocetto F, Barone B, Buonerba C, Contieri R, Pichler R, Subiela JD, Pradere B, Moschini M, Mari A, Mori K, Soria F, Mayr R, Jo JK, Gad M, Challacombe B, Abu-Ghanem Y, Mensah E, Nair R, Thurairaja R, Khan MS, Chung BI.

    The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data.

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . : .

    [doi:10.1016/j.urolonc.2025.07.005]

  • Pellegrino F, de Angelis M, Scilipoti P, Longoni M, Subiela JD, Contieri R, Afferi L, Zamboni S, Suardi N, Musi G, Luzzago S, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Fallara G, Roupret M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Matsumoto S, Fujii Y, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguie M, Bajeot AS, Resca S, Beatrici E, Lambert E, Mottrie A, Mir MC, Umari P, Teoh J, Wong C, Mertens LS, Pichler R, Mori K, Slusarczyk A, Poyet C, Albisinni S, Aziz A, Volpe A, Shariat S, Pradere B, Karakiewicz P, Necchi A, Ferro M, Montorsi F, Briganti A, Moschini M.

    Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

    BJU INTERNATIONAL . : .

    [doi:10.1111/bju.70018]

  • Pérez-Gutiérrez AM, Flórez G, Blanco V, Vázquez FL, Abellí-Deulofeu E, Ortega L, Serrano A, Arias F, Navarrete F, Fonseca F, Estévez V, Gómez Trigo J, Facal F, Arrojo M, Manzanares J, Muga R, Miquel L, Rodríguez de Fonseca F, Torrens M, Rubio G, Costas J.

    Predictive performance for alcohol use disorder of polygenic scores based on the general addiction risk factor and problematic alcohol use.

    DRUG AND ALCOHOL DEPENDENCE . 276: 112877-112877.

    [doi:10.1016/j.drugalcdep.2025.112877]

  • Molina-Cerrillo J, Roviello G, Bourlon MT, Studentova H, Fiala O, Cerbone L, Kucharz J, Ansari J, Zeppellini A, Taha T, Buti S, Ürün Y, Scagliarini S, Li H, Sunela K, Park SH, Rizzo M, Zgura A, Chiari R, Seront E, Catalano M, Ghosn M, Filosa A, Soares A, Massari F, Monteiro FSM, Grande E, Porta C, Bracarda S, Santoni M.

    Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study).

    INTERNATIONAL JOURNAL OF CANCER . : .

    [doi:10.1002/ijc.70228]

  • Domínguez Gutiérrez A, Hevia Palacios M, López Curtis DA, Muriel García A, Álvarez Díaz N, Javier BRF.

    Transcorporal Cuff-Placement in Artificial Urinary Sphincter Surgery: A Systematic Review.

    Urology . : .

    [doi:10.1016/j.urology.2025.11.222]

  • López CL, Sambo M, Orcajo-Rincon L, Durán-Poveda M, García JR, Santos RJ, Muñoz ML, Navarro-González E, Aller J, Pubul V, Guadalix S, Crespo G, González C, Zafón C, Navarro M, Sandi JS, Segura Á, Gajate P, Gómez-Balaguer M, Valdivia J, Reverter JL, Galofré JC, Castelo B, Villanueva MJ, Argüelles I, Casas JAV.

    Clinical and treatment patterns of advanced and radioiodine-refractory differentiated thyroid cancer. ERUDIT study.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-025-04122-6]